Picture EBD Group BioPharm America 2018 Boston September 600x60px
Document › Details

Idorsia Ltd.. (8/3/17). "Press Release: Idorsia Announces Half Year Results for 2017 – Successful Start of New Biopharmaceutical Company". Allschwil.

Organisations Organisation Idorsia Ltd. (SIX: IDIA)
  Group Idorsia (Group)
  Organisation 2 Johnson & Johnson (JnJ) (Group)
Products Product aprocitentan (ACT-132577)
  Product 2 nemorexant (proposed INN for ACT-541468)
Index term Index term Actelion–JnJ: investment, 201701–201706 acquisition $30b all-cash tender offer funded w JnJ cash held outside of US
Persons Person Clozel, Jean-Paul (Actelion 200607 CEO)
  Person 2 Clozel, Martine (Actelion 201108 CSO)

Record changed: 2017-08-10


Picture [LSF] – The Business Web Portal 600x80px

More documents for Idorsia (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSG] – The Business Web Portal 600x80px

» top